Relationship between lipid peroxidation and disease activity in patients with Behçet's disease
Introduction
Behçet's disease is a chronic multisystemic disorder which is characterized by a relapsing systemic inflammatory process, particularly affecting the vascular bed. A number of published reports showed that various functions of polymorphonuclear (PMN) leukocytes in peripheral blood, such as chemotaxis, phagocytosis, and superoxide radical anion (O2−) generation are increased in Behçet's disease 1, 2. PMN-mediated tissue injury has been thought to be a consequence of lysosomal degranulation 3, 4. However, neuthrophil-derived oxygen intermediates seem to contribute to tissue damage, especially in the endothelial tissue, more than lysosomal enzymes [5]. Neuthrophil-derived oxygen intermediates also affect lipid and lipoproteins and cause their oxidation. Therefore, oxidation products occur. Lipids and lipoprotein peroxidation are considered to be important in the pathogenesis of atherosclerosis 6, 7. Lipid and lipoprotein profiles and their relationship to atherogenesis in patients with Behçet's disease were described in previous studies 8, 9, 10. A way of estimating the free radical activity and lipid peroxidation is to determine the concentration of malondialdehyde (MDA) in plasma which is the most widely used test and is an easy initial screening test [11].
The aim was to reveal the relationships between MDA, lipid, lipoproteins and apoproteins in patients with Behçet's disease in the active and inactive periods.
Section snippets
Subjects
The study group included 18 patients with Behçet's disease (11 male and seven female with a mean age of 34.2; age range, 19–48) and 20 healthy control subjects (10 male and 10 female; mean age, 33.4; age range, 18–45). The diagnosis of Behçet's disease was made according to the criteria from the International Study Group for Behçet's disease [12]. Those patients who are allocated to the active period by clinical and laboratory findings were evaluated in this period. When the patients were in
Results
Parameters related to disease activity in patients in the active and inactive periods of the disease and control subjects were shown in Table 1. All parameters related to disease activity were found to be significantly different between active and inactive periods of the disease. PMN leukocyte count, PMN elastase activity and ESR levels were also found to be different between patients in the inactive period and control subjects.
The concentration of MDA and lipids, lipoproteins and
Discussion
Patients with Behçet's disease have been associated with alterations of plasma lipid and lipoprotein levels 9, 10. However, a comparison between plasma lipid, lipoprotein and lipid peroxidation has not previously been carried out in patients with Behçet's disease by considering the degree of disease activity. The selected biochemical parameters for representing the disease activity, especially PMN elastase levels, were evaluated in our previous studies 8, 13. Elastase is primarily located in
References (20)
- Niwa Y, Miyake S, Sakane T, Shingu M, Yokoyama M: Autooxidative damage in Behçet's disease-endothelial cell damage...
- Fulita Y, Yamada M, Asai K, Mimura Y: Generation of superoxide radical by neutrophils in Behçet's disease. Jpn J...
- Janoff A: At least three human neutrophil lysosomal proteases are capable of degrading joint connective tissues. Ann NY...
- Weisman G. Lysosomal mechanism of tissue injury in arthritis. N Engl J Med 286; 141–143,...
- Niwa Y, Miyake S, Sakane T, Shingu M, Yokoyamaş M: Auto-oxidative damage in Behçet's disease-endothelial cell damage...
- Loeper J, Ement J, Goy J, Bedu G: Lipid peroxidation during human atherosclerosis. IRCS Med Sci 11; 1035–1043,...
- Witztum JL, Steinberg D: Role of low density lipoprotein in atherogenesis. J Clin Invest 88: 1785–1792,...
- Örem A, Deǧer O, Çimşit G, Karahan SC, Akyol N, Yildirmiş S: Plasma lipoprotein (a) and its relationship with disease...
- Örem A, Deǧer O, Memiş Ö, Bahadır S, Ovalı E, Çimşit G: Lp(a) lipoprotein levels as a predictor of risk for...
- Mitamura T, Ohno S, Ariga H, Ohsaka T, Iwasaki N, Matsuda H, Matsumiya H: Lipoprotein cholesterol concentrations in...